| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Joshua S. Lev | Chief Financial Officer | 2025-11-12 | 2,166 | $6.18 | $13.39kSell |
| Daniel S. Goldberger | Chief Executive Officer | 2025-08-11 | 1,000 | $4.23 | $4.23kBuy |
| Thomas J. Errico | Director | 2025-08-11 | 15,000 | $4.47 | $67.05kBuy |
| John P. Gandolfo | Director | 2025-05-23 | 1,800 | $5.01 | $9.02kBuy |
| Thomas J. Errico | Director | 2025-05-12 | 10,000 | $4.77 | $47.74kBuy |
| Daniel S. Goldberger | Chief Executive Officer | 2025-03-17 | 1,000 | $8.59 | $8.59kBuy |
| Thomas J. Errico | Director | 2025-03-17 | 6,000 | $8.10 | $48.59kBuy |
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Joseph P. Errico | 48.30% | 3,861,942 | $20.31M | Insider |
| Merck Global Health Innovation Fund LLC | 41.85% | 3,346,032 | $17.60M | Insider |
| James L. L. Tullis | 25.19% | 2,014,110 | $10.59M | Insider |
| Thomas J. Errico | 12.67% | 1,013,106 | $5.33M | Insider |
| Core Ventures II LLC | 8.08% | 646,342 | $3.40M | Insider |
| Peter S. Staats | 5.96% | 476,419 | $2.51M | Insider |
| Charles Steve Theofilos | 5.79% | 462,758 | $2.43M | Insider |
| Francis R. Amato | 4.61% | 368,355 | $1.94M | Insider |
| Daniel S. Goldberger | 3.65% | 291,565 | $1.53M | Insider |
| Vanguard Group Inc | 2.92% | 233,473 | $1.23M | Institution |